Rational development of prophylactic HIV vaccines based on structural and regulatory proteins
- 16 October 2001
- Vol. 20 (3-4) , 304-321
- https://doi.org/10.1016/s0264-410x(01)00373-5
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- A Novel Recombinant Adeno-Associated Virus Vaccine Induces a Long-Term Humoral Immune Response to Human Immunodeficiency VirusHuman Gene Therapy, 2001
- The effect of HIV-1 regulatory proteins on cellular genes: derepression of the IL-2 promoter by TatEuropean Journal of Immunology, 2001
- Identification of a ComplexenvSubtype E HIV Type 1 Virus from the Democratic Republic of Congo, Recombinant with A, G, H, J, K, and Unknown SubtypesAIDS Research and Human Retroviruses, 2000
- Intranasal Immunization with HIV Reverse Transcriptase: Effect of Dose in the Induction of Helper T Cell Type 1 and 2 ImmunityAIDS Research and Human Retroviruses, 2000
- Characterization of Immune Escape Viruses from a Macaque Immunized with Live-Virus Vaccine and Challenged with Pathogenic SHIVKU-1AIDS Research and Human Retroviruses, 2000
- In Vitroandin VivoResponses to Interleukin 12 Are Maintained until the Late SIV Infection Stage but Lost during AIDSAIDS Research and Human Retroviruses, 2000
- CD8+ Lymphocyte Antiviral Activity in Monkeys Immunized with SIV Recombinant Poxvirus Vaccines: Potential Role in Vaccine EfficacyAIDS Research and Human Retroviruses, 1999
- The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 IsolatesPublished by Elsevier ,1996
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995